Is Your Payer Mix 2027-Ready? The Final Home Health Rule Sets Your Rate Landscape

The CY 2027 home health rule’s 2.4% aggregate payment estimate is not a forecast for every agency. This article explains how the temporary adjustment, case-mix and LUPA recalibration, Medicare Advantage contracts, and enrollment requirements affect practical revenue planning. It also gives owners a checklist for building a stronger 2027 model and preparing for buyer diligence.

11/9/20266 min read

Home health agency owner reviewing payer mix and 2027 payment planning.

The finalized CY 2027 home health payment rule includes a 2.4% estimated aggregate Medicare payment increase, alongside a separate 3.0% temporary adjustment to the national, standardized 30-day payment amount. For agency owners, the planning task is to understand how Medicare fee-for-service, Medicare Advantage contracts, episode mix, and enrollment compliance affect their own revenue outlook.

Quick-Scan Summary

Who this is for

Home health agency owners with $2 million to $10 million in revenue.
Operators planning 2027 budgets, reviewing payer mix, or considering a sale, succession, or ownership change.

Key takeaways

CMS estimates aggregate Medicare payments to home health agencies will increase 2.4%, or $415 million, compared with CY 2026. That is not an individual agency rate guarantee.
CMS also finalized a separate 3.0% temporary adjustment to the national, standardized 30-day payment amount. The fact sheet does not provide one net figure combining this adjustment with the aggregate estimate.
Your agency’s outcome depends on its own payment mix, case mix, LUPA frequency, wage index, and outlier payments.
Medicare Advantage rates follow your contract, not the Medicare fee-for-service payment rule.
Enrollment standing and ownership records deserve close attention. Certain majority ownership changes require Medicare reenrollment and a survey or accreditation.

What the final rule sets

CMS issued the final CY 2027 rule on November 4, 2026. Its aggregate payment estimate combines a payment update and an estimated change related to the fixed-dollar loss amount.

The 2.4% aggregate estimate and the 3.0% temporary adjustment are separate figures. CMS presents both, but does not publish a single net rate change that combines them. Do not treat the headline increase as a forecast of your agency’s net payment change.

CMS also described earlier permanent adjustments associated with its analysis of assumed and actual behavior changes under PDGM:

Home health payment planning board showing case mix, wage index, and outlier factors.

CMS also finalized a 3.0% temporary reduction in CY 2026. The CMS fact sheet explains that CY 2027’s temporary adjustment continues recoupment of retrospective overpayments for CYs 2020 through 2025.

Why the aggregate number is not your number

The 2.4% figure describes CMS’s estimate across home health agencies. Your individual results depend on how the rule’s components intersect with your patients, operations, and payer contracts.

CMS recalibrated PDGM case-mix weights, functional levels, comorbidity adjustment subgroups, and LUPA thresholds using CY 2025 data. Those changes may affect agencies differently depending on the episodes they provide. Your LUPA frequency and outlier experience matter too. So does your wage index, which affects payment calculations.

CMS responded to comments on a request for information about a possible home health-specific wage index using an alternate data source, such as Bureau of Labor Statistics data. The final rule does not announce an implementation plan or finalized methodology for a new wage index.

Agency leaders comparing Medicare fee-for-service and managed care forecasts.

A 2027 payer mix readiness framework

Start with your own claims and contracts, not the national headline. Build two scenarios for Medicare fee-for-service using your agency’s actual episode mix and the finalized rule components. The scenarios should show the assumptions you are testing, rather than imply a CMS-published net rate.

Separate fee-for-service from Medicare Advantage. Medicare Advantage payment depends on the terms of each plan contract, not the fee-for-service rate update. Refresh contract economics plan by plan, and measure performance using:

Net reimbursement per completed visit by payer.
Authorized visits compared with clinically ordered visits.
Denials and appeal overturn rates.
Authorization labor hours per 100 Medicare Advantage episodes.
Days in accounts receivable by payer.
EBITDA margin by payer.
Revenue concentration by individual Medicare Advantage plan.
Referral volume by payer and referral source.

Then compare your own LUPA incidence and case-mix distribution with your claims history. If the types of episodes you provide do not match the assumptions in your current forecast, update the forecast. Keep the wage index issue on your monitoring list, but do not budget for a methodology CMS has not finalized.

Enrollment integrity is revenue protection

The rule raises the financial stakes of Medicare enrollment noncompliance. According to the CMS fact sheet, certain revocations previously took effect 30 days after notice was mailed. CMS finalized a policy making all revocation grounds retroactive to the date noncompliance began.

Home health owner reviewing enrollment and ownership records with a successor.

The majority ownership rule matters if you are considering a sale or restructuring. Not every ownership change is necessarily covered, so identify the proposed transaction structure and confirm whether the reenrollment requirement applies before relying on an assumed timeline or continuity of enrollment.

Home Health Care News reports that CMS estimates the enrollment provisions will save taxpayers approximately $82 million annually. CMS Administrator Mehmet Oz said the changes would “help protect seniors, safeguard taxpayer dollars, and preserve access to the care beneficiaries need.” Most of the fraud-focused provisions apply across Medicare provider types, not only home health.

Service-line and reporting notes

The rule acknowledges home health’s role in palliative care and says CMS will provide examples through future sub-regulatory guidance. This is not a new benefit or a promise of additional revenue. Treat it as an area to monitor for guidance.

A separate Medicare Part B DME benefit change takes effect April 1, 2027. It expands coverage to certain external infusion pumps and associated home infusion drugs when three criteria are met: FDA prescribing information calls for administration by or under a healthcare professional’s supervision; a qualified home infusion therapy supplier administers or supervises the drug in the home; and the drug is to be infused at least 12 times per year. This is a DME benefit change, not a home health payment change.

For the CY 2027 Home Health Quality Reporting Program, CMS finalized assessment data submission deadlines and changed OASIS and HHCAHPS Annual Payment Update reporting timeframes to cover a calendar year of data, January 1 through December 31. Review your data submission workflow and responsibilities so teams are prepared for the calendar-year reporting timeframe.

Buyer diligence and valuation implications

For a buyer evaluating an agency, a well-supported 2027 model is more useful than a forecast built around the 2.4% headline. Clear payer-level economics, claims-based case-mix analysis, enrollment standing, and accurate ownership records make it easier to understand both earnings and risk.

Consider an illustrative agency with $750,000 in normalized EBITDA. At a 5.0 multiple, the example value is $3.75 million. At a 5.25 multiple, it is $3.9375 million, a difference of $187,500. This is an illustration, not a valuation or market quote. It shows why buyers scrutinize the reliability of earnings and the risks that could affect them. The rule does not establish a sale multiple or predict an individual agency’s value.

What owners can do now

Build a two-scenario Medicare fee-for-service model for 2027 using your own claims and clearly stated assumptions.
Pull your LUPA frequency and case-mix distribution from agency claims, then review the effects of the finalized recalibration.
Refresh Medicare Advantage contract economics and the payer-level measures listed above.
Verify Medicare enrollment and ownership records. Flag any planned ownership change for review against the reenrollment requirement.
Prepare your team for the CY 2027 QRP calendar-year data reporting timeframe.

So what should you do now?

Ask finance to separate Medicare fee-for-service forecasts from Medicare Advantage contract forecasts.
Have operations validate LUPA, episode mix, authorization, and denial data.
Confirm that ownership and enrollment records are current before planning a transaction.
If sale or succession is on the horizon, organize support for your earnings and payer assumptions before a buyer asks.

Plain-Language Glossary

PDGM: The Patient-Driven Groupings Model, Medicare’s home health payment model.
Case-mix weight: A factor used to adjust payment based on a patient’s characteristics and care needs.
LUPA: A low-utilization payment adjustment that applies when an episode has fewer visits than its applicable threshold.
FDL: Fixed-dollar loss amount used in calculating eligibility for outlier payments.
Outlier payment: Additional payment for periods of care with unusually high costs that exceed a threshold.
Temporary adjustment: A short-term payment adjustment used to address retrospective overpayments.
Permanent adjustment: A lasting change to the base payment amount.
Retroactive revocation: A Medicare enrollment revocation effective from the date noncompliance began.
CHOW: Change of ownership.
Wage index: A geographic factor used in Medicare payment calculations.
RFI: Request for information. It gathers input and does not itself establish a policy.
HH QRP: Home Health Quality Reporting Program.
APU: Annual Payment Update.
HHVBP: Home Health Value-Based Purchasing Model.
EBITDA: Earnings before interest, taxes, depreciation, and amortization.
Normalized EBITDA: EBITDA adjusted to represent ongoing business operations.
Multiple: A factor applied to EBITDA in an illustrative valuation calculation.

Explore a sale or partnership with Senate Healthcare

Senate Healthcare LLC is the buyer and strategic partner pursuing home health or hospice agency acquisitions. We are not a broker or advisor. Your agency does not need to be perfectly positioned today to begin a confidential conversation about reducing risk, improving readiness, and exploring a sale or partnership with Senate Healthcare. We make no assumptions about your timeline or transaction fit before learning about your goals and operations.

Resources:

Unlock Your 30-Minute Agency Succession Review

Maybe you're ready to expand your reach, or perhaps it's time to consider your legacy and the future of your business. Either way, it all begins with a conversation. Schedule a confidential, no-obligation call to explore what the future might hold for you and your business.

Complete the form, and we'll reach out for a chat...